EKEvgeniy N. Kolesnikov

Evgeniy N. Kolesnikov

*This is an algorithmically generated author record based on publicly available information.

Evgeniy N. Kolesnikov has a total of 184 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Results of the ESOSTAT multiple-center prospective study: analysis of 90-day postoperative morbidity and mortality after radical surgery for esophageal and esophagogastric junction cancer

    by A.B. Ryabov, N.M. Abdulkhakimov, V.G. Agadzhanov, M.V. Agasiev, A.E. Anisimov, G.V. Afonin, A.F. Bikmetov, F.P. Vetshev, S.V. Gamayunov, D.V. Erygin, et al.

    Objective. To evaluate 90-day morbidity and mortality rates after elective radical surgery for esophageal and esophagogastric junction cancer within the prospective multiple-center study ESOSTAT. Material and methods. The study included 230 patients from 18 oncology hospitals in the Russian Federation and the Republic of Belarus who underwent elective radical esophagectomy for primary esophageal cancer or esophagogastric junction cancer (Siewert I–II) between March 18 and September 18, 2024. Complications were uniformly recorded using the ESODATA system with severity graded according to the Clavien-Dindo classification. Univariate and multivariate logistic regression analyses were performed to identify risk factors of postoperative complications and mortality. Results. The 90-day mortality rate was 8.7%, in-hospital mortality — 4.8%. The overall complication rate was 41.3%, including surgical complications in 26.5% of patients and redo surgeries in 17.4% of cases. The most common complications were pulmonary (22.1%) and anastomotic leakage (11.3%). The mortality rate associated with anastomotic leakage was 19.2%. Multivariate analysis identified female sex (OR=0.732; 95% CI 0.548–0.978; p=0.035), ECOG status 2 (OR=10.142; 95% CI 1.575–65.366; p=0.015), surgery time (OR=1.003; 95% CI 1.001–1.005; p=0.006), and intraoperative blood loss (OR=1.001; 95% CI 1.000–1.002; p=0.027) as independent predictors of complications. Factors independently associated with 90-day mortality were Charlson comorbidity index >4 (OR=1.260; 95% CI 1.062–1.495; p=0.008), complicated course of esophageal cancer (OR=1.560; 95% CI 0.637–2.305; p=0.025), concomitant pulmonary diseases (OR=3.328; 95% CI 1.083–10.227; p=0.036), and any postoperative complication (OR=36.554; 95% CI 15.800–84.521; p<0.001). Conclusion. The ESOSTAT study is the first in Russia and Belarus to evaluate 90-day morbidity and mortality rates after esophagectomy. Our findings are comparable with international registries, support 90-day follow-up period and identify key prognostic factors. Risk factor analysis will allow patient stratification according to the likelihood of adverse outcomes, facilitate more rigorous patient selection, and ultimately improve safety of surgical treatment.

  • Open Access

    Combination of stereotactic radiotherapy and intra-arterial chemoembolization in the treatment of a patient with unresectable pancreatic cancer

    by O. I. Kit, V. I. Voshedskii, P. G. Sakun, E. N. Kolesnikov, G. Yu. Egorov, E. A. Dzhenkova, L. Ya. Rozenko, S. G. Vlasov, M. A. Komandirov, E. A. Kashchaeva, et al.

    Pancreatic cancer (PC) is one of the most aggressive malignancies. The 5-year overall survival rate for this disease is only approximately 6%, with a median survival of 13.6 months. Despite advances in surgical approaches and systemic therapy, the 5-year survival rate continues to decline. Currently, complete cure can only be achieved through radical surgical resection of the tumor at an early stage of the disease. Involvement of critical abdominal structures significantly complicates surgical intervention. In such cases, neoadjuvant therapy may increase the likelihood of achieving an R0 resection. In terms of the type of radiation used in the preoperative setting, stereotactic body radiation therapy (SBRT) is an alternative to conventional fractionated radiation therapy. It offers greater convenience by minimizing prolonged interruptions in systemic therapy and has a favorable toxicity profile. This article presents a clinical case describing the patient's course from the outpatient stage of medical care through follow-up examination after completion of multimodal treatment. A clinical case demonstrating the effective use of stereotactic radiotherapy in combination with intra-arterial chemoembolization as part of the comprehensive treatment of a patient with locally advanced PC is presented. The report is of particular interest to oncologists and radiation oncologists, as it demonstrates the high efficacy of multimodal therapy for locally advanced PC.

  • Open Access

    Gastroenterostomy in non-Hodgkin B-cell lymphoma complicated by decompensated gastric outlet obstruction

    by M. S. Kazanchyan, Ya. S. Gaysultanova, N. V. Nikolaeva, A. V. Snezhko, I. B. Lysenko, L. Yu. Vladimirova, D. S. Petrov, Yu. A. Fomenko, E. N. Kolesnikov, Я. С. Гайсултанова

    Primary gastric non- Hodgkin lymphomas represent the most common extranodal localization of lymphoproliferative disorders. The current standard of care, first-line immunochemotherapy based on rituximab (R-CHOP and CHOP-like reg imens), demonstrates high efficacy, achieving complete response in the majority of patients. However, 8–25 % of patients develop local life-threatening complications during or after treatment, among which gastric outlet obstruction (pyloric stenosis) is the most common. In routine clinical practice, elective surgical intervention is generally not performed in patients with lymphomas because these tumors are highly sensitive to systemic drug therapy. This article presents a clinical case of a 49-year-old patient with stage IV extranodal B-cell gastric lymphoma and HIV-positive status, demonstrating the role of palliative surgical intervention. Despite achieving a partial metabolic response to polychemotherapy (EPOCH/R-CHOP regimens), the patient developed decompensated cicatricial- tumorous pyloric stenosis. This complication required active surgical management. Gastrojejunostomy was successfully performed as a palliative procedure, creating a bypass for gastric emptying into the jejunum while circumventing the obstruction site, which significantly improved the patient's quality of life. The postoperative course was uneventful, and no signs of progression of the underlying lymphoproliferative disease were observed during long-term follow-up. An additional advantage of the selected surgical approach was the rapid restoration of the patient's nutritional status while preserving oral feeding. The presented clinical case confirms the feasibility of an individualized approach to the selection of palliative treatment strategies in patients with complicated gastric lymphoma.

  • The results of surgical interventions for colon cancer with spread to the organs of the pancreatoduodenal zone

    by Yu.A. Gevorkyan, N.V. Soldatkina, E.N. Kolesnikov, A.V. Dashkov, M.B. Ter-Grigoryants, I.N. Mironenko, O.K. Bondarenko, O.I. Kit

    Objective. The aim of the study — to study the immediate and long-term results of surgical interventions for colon cancer with spread to the organs of the pancreatic duodenal zone. Research methods. A retrospective analysis of 38 cases of treatment of malignant tumors of the colon involving the pancreatoduodenal zone in the Federal State Budgetary Institution “NMIC of Oncology” of the Ministry of Health of the Russian Federation from 2013 to 2024 was carried out. All patients underwent combined surgical procedures, including right- or left-sided hemicolectomy with duodenal resection (34.2%), atypical or distal pancreatic resection (26.3%), corporocaudal pancreatic resection (21.1%), pancreatoduodenal resection (18.4%). Results. The average volume of intraoperative blood loss was 300 ml, and the average duration of surgery was 280 minutes. The greatest volume of intraoperative blood loss and duration of surgery were observed in combined hemicolectomy with corporocaudal resection of the pancreas. Postoperative complications developed in 15 out of 38 patients (39.5%). Postoperative pancreatitis (13.2%), pancreatic necrosis, external pancreatic fistula and intra-abdominal bleeding (5.3% each) and repeated surgical interventions prevailed 4 (10.5%) patients were treated (ileotransverzoanastomosis failure, small intestine perforation, intra-abdominal bleeding, pancreatic necrosis). Two cases resulted in death in the early postoperative period (5.3%). To date, 15 out of 38 patients (39.5%) are alive, 23 (60.5%) patients have died. The 75%, 50%, and 25% survival rates of the subgroup of patients with duodenal resection were 4.5, 22.5, and 45.3 months, respectively. Conclusion. Surgical interventions for colon cancer with spread to the organs of the pancreatoduodenal zone are technically complex surgical interventions, with a frequency of postoperative complications and a postoperative mortality rate above the average for colon cancer. Nevertheless, in combination with chemotherapy, they can achieve good long-term treatment results.

  • Results of Transarterial Chemoembolization in Treatment of Primary and Metastatic Liver Cancer: Clinical Assessment

    by I. I. Solodov, Yu. S. Shatova, A. Yu. Maksimov, E. N. Kolesnikov, A. P. Menshenina, N. D. Ushakova, N. V. Soldatkina, A. V. Snezhko, G. Yu. Egorov, A. V. Galina, et al.

    Introduction. Hepatocellular carcinoma is the third leading cause of cancer death worldwide with an extremely low five-year survival rate (20.3%) and colorectal cancer liver metastases accounting for significant 10–20% of all secondary tumors. Transarterial chemoembolization (TACE) represents a standard method of local palliative treatment; however, after the procedure, a stable hypoxic environment is formed contributing to aggressive relapses and further progression of the disease. The present study aims to assess the clinical efficacy and safety of TACE in patients with primary and metastatic liver cancer. Materials and methods. A retrospective analysis is conducted for 333 patients (181 men, 152 women) aged 19 to 83 years (mean age of 60.1 ± 0.55 years) treated at the National Medical Research Center for Oncology (Rostov-on-Don, Russian Federation). A total of 93 patients are diagnosed with hepatocellular carcinoma (ICD-10 C22.0); 240 have colorectal cancer metastases to the liver (ICD-10 C78.7). All underwent the TACE procedure. Two-year survival is analyzed using life tables, Kaplan-Meier method and Cox regression analysis to examine risk factors. Statistical analysis is performed using the Statistica 10 software. Results and discussion. During two years of observation, 61.9% of patients died; the overall survival rate is 38.1%. The highest risk of death was observed in the first two months after TACE, remaining high until the eighth month. A Kaplan-Meier analysis shows a significant reduction in survival after five months. Risk factors include disease stage, tumor morphology and patient gender: metastatic disease and male gender were associated with lower survival. Conclusion. Overall survival after TACE remains low, especially in the first months. The identified risk factors can be used for more accurate identification of high-risk groups to optimize combined therapy and develop more effective treatment strategies.

  • Treatment of cancer in tubular villous colorectal adenomas

    by O.I. Kit, Yu.A. Gevorkyan, N.V. Soldatkina, V.M. Legostaev, E.N. Kolesnikov, O.K. Bondarenko, E.N. Mironenko, D.S. Petrov

    Objective. To study the results of treatment of cancer in tubular villous colorectal adenomas. Material and methods. A retrospective analysis included 51 patients with cancer in tubular villous colorectal adenomas cTis-T1N0M0 between 02.2019 and 09.2021. The median age of patients was 64 (57; 71) years. Minimally invasive interventions were performed in all patients (transanal endoscopic microsurgical resection of the rectum — 25 cases, endoscopic submucosal dissection — 20 cases, laparoscopic resection of the intestine — 6 cases). Results. Intraoperative complications (intestinal wall perforation) developed in 1 (2%) patient, early postoperative complications (intestinal bleeding from suture line) — in 2 (4%) patients. Throughout the follow-up period (29—84 months), tumor recurrence was detected in 2 (4%) patients with rectal primary tumor, colorectal polyps — in 8 (15.7%) patients. Eleven (21.6%) patients had previous malignant tumors. Conclusion. The study demonstrated favorable oncological and surgical results of treatment of cancer in tubular villous colorectal adenomas. Minimally invasive interventions are safe and predictable, as well as accompanied by low incidence of complications.


  • Open Access

    Dynamics of thioredoxin 1, thioredoxin reductase 1 and glutathione-S-transferase Pi content in the spleen and liver of rats during the latent period of growth and metastasis of sarcoma C45

    by E. I. Surikova, E. M. Frantsiyants, I. V. Kaplieva, I. V. Neskubina, E. G. Shakaryan, A. V. Snezhko, E. N. Kolesnikov, V. A. Bandovkina, L. K. Trepitaki, Yu. A. Petrova, et al.

    Purpose of the study. To examine the dynamics of the content of thioredoxin 1 (Trx1), thioredoxin reductase 1 (TR1), and glutathione S-transferase Pi (GST Pi) in the spleen and liver during the latent period of growth and metastasis of C45, which occurs approximately one to two weeks after tumor transplantation. Materials and methods. The experiment was conducted on 28 male rats of a white, nonlinear strain. A model of hematogenous metastasis to the liver was created by transplanting sarcoma 45 (C45) into the spleen, which was previously dislocated under the skin three weeks prior to the commencement of the experiment. The experimental Groups were as follows: Group 1 (n = 7) comprised intact rats; Group 2 (n = 7) comprised rats in which the spleen was dislocated under the skin; Group 3 (n = 7) comprised rats one week later; and Group 4 (n = 7) comprised rats two weeks later. In each case, the rats had undergone transplantation of C45 into the spleen, which had been dislocated under the skin. The concentrations of Trx1, TR1, and GST Pi were quantified in spleen and liver homogenates through the use of enzyme linked immunosorbent assay (ELISA). Results. Group 1 exhibited a significantly elevated (p ≤ 0.01) Trx1 and TR1 level in the liver, at 8.3 and 3.4 times higher, respectively, in comparison to the spleen. Conversely, the GST Pi level did not demonstrate a notable discrepancy between the two organs. Group 2 exhibited elevated TR1 levels in the spleen and diminished TR1 and Trx1 levels in the liver relative to Group 1. In Group 3, spleen Trx1 and TR1 increased, while in Group 4, these levels were elevated by 1.7 (p ≤ 0.05) and 5.5 (p ≤ 0.001) times, respectively, compared to Group 1. Additionally, Group 4 exhibited lower GST Pi levels on average by 2. The results demonstrated a statistically significant increase in Trx1 and TR1 levels in Groups 3 and 4, with a threefold increase (p ≤ 0.05) in Groups 3 and 4 compared to Group 1. In the liver, Trx1 and TR1 levels were found to be 4.6 and 1.8 times lower ( p ≤ 0.001) in Group 3 compared to Group 1. In Group 4, Trx1 remained lower (2.9 times, p ≤ 0.01), while TR1 levels were restored to the level observed in Group 1, along with GST Pi. Conclusion. The initially greater significance of the Trx system for liver homeostasis than that of the spleen is obvious. During the latent period of C45 growth and metastasis, the antioxidant and redox regulating functions of the Trx system were activated in the spleen, while in the liver, it was inhibited, disrupting the antioxidant and redox homeostasis of the organ. The activity of detoxification and glutathionylation processes regulated by GST Pi decreased in the latent period in the spleen, while in the liver it corresponded to the level in the intact organ. The results reflect the possible mechanism of an imbalance in the protective metabolic systems of the liver during the latent period of metastasis, forming the basis for it.


  • Molecular aspects of predicting recurrence of retroperitoneal extraorgan liposarcomas

    by E. N. Kolesnikov, R. A. Maksimov, S. I. Demidov, N. N. Timoshkina, S. N. Vlasov

    Purpose of the study. The aim of the work was to optimize the prognosis of recurrences of retroperitoneal extraorgan liposarcomas of various degrees of differentiation by detecting microRNAs (miRNAs) of tumor cells with differential expression depending on the course of the malignant disease.Materials and methods. The study was conducted on 96 patients: 19 patients with lipomas and 77 patients with retroperitoneal extraorgan liposarcomas. Tissue samples were obtained during the operation. Among patients with malignant diseases, highly differentiated liposarcoma (VDLS) was detected in 51 patients, and dedifferentiated (DDLS) in 26 patients. miRNA expression levels in tumor cells were determined using real-time PCR.Results. During the follow-up period, relapses of malignant disease were detected in 25 (32,5%) people: 13 (25,5%) among patients with VDLS and 12 (46,2%) among patients with DDLS. In DDLS, characterized by a more aggressive course, there was an increased level of expression of miRNA155, -21, -26a2 and a decrease in expression of miRNA15a and -34 compared with patients with VDLS. In patients with recurrent retroperitoneal liposarcomas, the expression of miRNA15a was initially 83% lower in tumor cells of surgical samples (pConclusion. The determination of the expression of miRNA155, -26a2, -34, -15a in tumor cells during surgical treatment of patients with retroperitoneal liposarcomas is an effective way to assess the risk of recurrence and is relevant for determining the tactics of further treatment of patients.

  • Open Access

    Research on the expression of E-cadherin in lung cancer tumors with different histological structures

    by E. N. Kolesnikov, O. N. Stateshny, D. A. Kharagezov, E. A. Mirzoyan, T. G. Ayrapetova, A. G. Milakin, K. D. Iozefi

    Purpose of the study. To conduct a comparative analysis of E-cadherin expression in inoperable patients with non-small cell lung cancer (NSCLC) cells and with different survival rates.Materials and methods. The study included 96 patients with inoperable NSCLC: 84 (87.5 %) men and 12 (12.5 %) women, whose average age was 62.4 ± 0.68 years. Squamous cell carcinoma (SCC) was diagnosed in 78 (81.25 %) patients, and adenocarcinoma (AC) with a tumor differentiation grade of G2-G3 in 18 (18.75 %). The patients were treated and monitored at the National Medical Research Centre for Oncology. The expression of cadherins was determined in the tumor cells of the biopsy specimens. The obtained data have been processed using the Statistica 13.0 program (StatSoftInc., USA). The studied data have been checked for compliance with the normal distribution using the Shapiro-Wilk criterion.Results. The following distribution of patients with NSCLC was noted: IIA – 2 (2.1 %), IIB – 14 (14.6 %), IIIA – 51 (53.1 %), IIIB – 29 (30.2 %), i. e. the frequency of stage III is higher than stage II (83.3 % (n = 80) versus 16.7 % (n = 16), p < 0.001). Fatal outcome occurred in the SCC group within 1 year in 28 patients, within 1 to 2 years – in 30, 20 patients survived for 3 years or more. For AC, these figures were 6,5 and 7 respectively. The analysis revealed that E-cadherin expression was noted in both squamous cell carcinoma and lung adenocarcinoma: Me 55 [LQ 37; UQ 65] and Me 50 [LQ 40; UQ 70], respectively.Conclusions. 1. The analysis revealed that E-cadherin expression was observed in both squamous cell carcinoma and lung adenocarcinomas without statistically significant differences between the compared groups (p = 0.25). 2. Statistically significant differences in the levels of E-cadherin expression were noted in the biopsy samples of the 2 groups only with survival up to 1 year and up to 3 years or more (p < 0.05).

  • Open Access

    Results of rectal resection in metastatic cancer

    by O. I. Kit, Yu. A. Gevorkyan, N. V. Soldatkina, E. N. Kolesnikov, M. A. Gusareva, O. K. Bondarenko, A. E. Anisimov, L. Y. Vladimirova

    Результаты резекции прямой кишки при метастатическом раке